Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-30
1991-01-01
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 5142268, 5142282, 5142285, 5142288, 5142328, 514241, 514242, 514247, 514255, 514256, 514269, 514338, 514361, 514362, 514363, 514375, 514366, 514378, 514381, 514386, 514397, A61K 31415, A61K 3154, A61K 31535, A61K 3153, A61K 3150, A61K 31495, A61K 31505, A61K 3144, A61K 3141, A61K 31425, A61K 3142
Patent
active
049818643
ABSTRACT:
The present invention is concerned with the use of compounds of the general formula: ##STR1## wherein R.sub.1 is a phenyl radical of the general formula: ##STR2## or R.sub.1 is a 5 or 6 membered heterocycle or when X is a valency bond R.sub.1 is also H, OH, mercapto, amino, alkyl, alkenyl, alkynyl, haloalkyl, alkylthio, formylaminoalkyl, pyridylcarbonylamino, cycloalkyl, or cycloalkenyl, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl or hydroxyalkyl of claim 1 or 2 for the preparation of pharmaceutical compositions with an erythrocyte aggregation inhibition action useful, for example, in states of shock or circulatory disturbance.
REFERENCES:
patent: 4666923 (1987-05-01), Holck et al.
patent: 4695567 (1987-09-01), Mertens et al.
patent: 4710510 (1987-12-01), Mertens et al.
patent: 4730003 (1988-03-01), von der Saal et al.
patent: 4810801 (1989-03-01), Mertens et al.
patent: 4831032 (1989-05-01), von der Saal et al.
patent: 4874756 (1989-10-01), Mertens et al.
Chemical Abstracts, vol. 106: 213949k (1987).
Boehm Erwin
Hoelck Jens-Peter
Martin Ulrich
Mertens Alfred
Von Der Saal Wolfgang
Boehringer Mannehim GmbH
Robinson Douglas W.
Weddington Kevin E.
LandOfFree
Method for inhibition of erythrocyte aggregation using anellated does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibition of erythrocyte aggregation using anellated, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibition of erythrocyte aggregation using anellated will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1996496